Treatment Safety, Supply and Access

The safety and supply of treatment products is a key concern for the bleeding disorders community.

Since the 1970's and 1980's, when many people in our community were infected with human immunodeficiency virus (HIV) and hepatitis C (HCV) through the use of clotting factor concentrates, WFH has made it a priority to closely monitor product safety, supply, and access. The WFH issues advisories related to treatment safety and supply. We also monitor the development and regulatory status of new and novel treatments.

WFH Network

WFH USA advances the global mission of the WFH in the United States.
Congress & Meetings
The latest information about WFH meetings and events.
eLearning Platform
Easy access to all WFH bleeding disorder resources.
Hemophilia World News
Access news about the WFH and bleeding disorders care around the world.


Visit us on Facebook

Contact Us

  • 1425, boul. René-Lévesque Ouest
    Bureau 1200 
    Montréal, Québec H3G 1T7 Canada
    Tel.: +1 (514) 875-7944
    Fax: +1 (514) 875-8916
    Email: [email protected]

Français / Español / 简体中文 / русский / العربية / 日本語